dockets: FDA-2005-N-0169
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2005-N-0169 | FDA | Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers | Nonrulemaking | 2021-09-01T01:01:17Z | 0b00006480440bbc |
Links from other tables
- 2 rows from docket_id in documents